📣 VC round data is live. Check it out!
- Public Comps
- Airway Medix
Airway Medix Valuation Multiples
Discover revenue and EBITDA valuation multiples for Airway Medix and similar public comparables like BioRegenx, Cuprina Holdings (Cayman), Etropal, Momina Krepost and more.
Airway Medix Overview
About Airway Medix
Airway Medix SA focuses on research, development, and commercialization of devices for single use in mechanically ventilated patients at Intensive Care Units as well as in patients with life-threatening and anaesthesiologic wards. The company's products include the Closed Suction System, the Oral Care System, and the Cuff Pressure Regulator.
Founded
2013
HQ

Employees
632
Website
Sectors
Financials (FY)
EV
$13M
Valuation Multiples
Start free trialAirway Medix Financials
Airway Medix reported last fiscal year revenue of $1K and EBITDA of $956K.
In the same fiscal year, Airway Medix generated ($12K) in gross profit, $956K in EBITDA, and $480K in net income.
Airway Medix P&L
In the most recent fiscal year, Airway Medix reported revenue of $1K and EBITDA of $956K.
Airway Medix is profitable as of last fiscal year, with gross margin of (1125%), EBITDA margin of 86900%, and net margin of 43650%.
Financial data powered by Morningstar, Inc.
Airway Medix Stock Performance
Airway Medix has current market cap of $9M, and enterprise value of $13M.
Market Cap Evolution
Airway Medix's stock price is $0.08.
Airway Medix share price increased by 0.2% in the last 30 days, and decreased by 34.5% in the last year.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13M | $9M | -0.4% | 0.2% | -9.4% | -34.5% | $0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAirway Medix Valuation Multiples
Airway Medix trades at 11589.3x EV/Revenue multiple, and 13.3x EV/EBITDA.
Airway Medix Financial Valuation Multiples
As of May 26, 2026, Airway Medix has market cap of $9M and EV of $13M.
Airway Medix has a P/E ratio of 19.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Airway Medix Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Airway Medix Margins & Growth Rates
In the most recent fiscal year, Airway Medix reported gross margin of (1125%), EBITDA margin of 86900%, and net margin of 43650%.
Airway Medix Margins
Airway Medix Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Airway Medix Operational KPIs
Airway Medix's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Airway Medix Competitors
Airway Medix competitors include BioRegenx, Cuprina Holdings (Cayman), Etropal, Momina Krepost, Balsm Alofoq, Standard Dental Labs, Farmaceutica Remedia, Ortivus, Odinwell and iZafe Group.
Most Airway Medix public comparables operate across Medical Supplies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| — | — | — | — | |||
| 95.4x | — | (1.0x) | — | |||
| 1.4x | — | 17.9x | — | |||
| 7.1x | — | (7.0x) | — | |||
| 2.3x | — | 12.6x | — | |||
| — | — | — | — | |||
| 0.0x | — | 1.0x | — | |||
| 2.4x | — | (12.2x) | — | |||
This data is available for Pro users. Sign up to see all Airway Medix competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Airway Medix
| When was Airway Medix founded? | Airway Medix was founded in 2013. |
| Where is Airway Medix headquartered? | Airway Medix is headquartered in Poland. |
| How many employees does Airway Medix have? | As of today, Airway Medix has over 632 employees. |
| Is Airway Medix publicly listed? | Yes, Airway Medix is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Airway Medix? | Airway Medix trades under AWM ticker. |
| When did Airway Medix go public? | Airway Medix went public in 2014. |
| Who are competitors of Airway Medix? | Airway Medix main competitors include BioRegenx, Cuprina Holdings (Cayman), Etropal, Momina Krepost, Balsm Alofoq, Standard Dental Labs, Farmaceutica Remedia, Ortivus, Odinwell, iZafe Group. |
| What is the current market cap of Airway Medix? | Airway Medix's current market cap is $9M. |
| What is the current revenue of Airway Medix? | Airway Medix's last fiscal year revenue is $1K. |
| What is the current EV/Revenue multiple of Airway Medix? | Current revenue multiple of Airway Medix is 11589.3x. |
| Is Airway Medix profitable? | No, Airway Medix is not profitable. |
| How many companies Airway Medix has acquired to date? | Airway Medix hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Airway Medix has invested to date? | Airway Medix hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Airway Medix
Lists including Airway Medix
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.